about
Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors.A Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome-Review of the Literature.PDE-constrained multispectral imaging of tissue chromophores with the equation of radiative transfer.The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review.Correlation of tumor-associated macrophages and clinicopathological factors in Wilms tumor.Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis.HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma.High-Dose, Single-Fraction Irradiation Rapidly Reduces Tumor Vasculature and Perfusion in a Xenograft Model of Neuroblastoma.Regulation of endocytic processes by pH.Biology and genetics of human neuroblastomas.Inhibition of Notch promotes liver metastasis.Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts.Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab.A common symptom of an uncommon disease.Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2.Acidification of endocytic vesicles and the intracellular pathways of ligands and receptorsAnti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumorSuppression of primary tumor growth in a mouse model of human neuroblastomap53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive diseaseErythema nodosum arising during everolimus therapy for tuberous sclerosis complexTranscription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
P50
Q30447306-F1A0B253-BC86-4377-8E0D-713F1D473D1AQ33770113-B4302DF2-FA6B-443D-A8E1-BE205D96CA25Q34476229-897454EC-C9C3-4749-B520-37DA8DC59DE4Q34980333-6FB8C600-1954-4E5C-97CE-FF4388F85FFAQ36722631-20FFDB88-F025-4ED1-A27D-6AD5664B3AB8Q37360514-F34CAB21-2D88-42AC-864F-30010197F9F8Q37387937-7502F5B3-9F2F-4E72-AB53-596F036DDFFCQ38791587-B529C99A-E9E7-407F-BF8D-03493605AB13Q39574273-885459EA-A9FA-4BD8-8659-DE43A0D1118DQ41469169-42507664-E83B-4BD7-B739-34D1632EDCABQ43227175-9973469C-9E19-4177-B58C-2B351834BBD1Q43904918-0CF5012A-2608-4221-87C1-FF9B822EF94AQ46186663-3B488DCF-3B72-4AFF-83DD-D3F9B251E8FDQ50803244-2EBA8EAE-746A-4417-9031-D68CC0E161E3Q71953373-3F99F004-C660-4058-B099-BB16800F8601Q72732278-1E4BEE20-C101-409B-8076-E084A92EEBF6Q73383545-B700E9C8-0DD9-4DD9-9A50-D1EB678B8F3AQ73937488-9E4BAE1A-1F07-4DF4-91FC-EB85DA77FF8BQ77726363-3E4FE4C8-9033-4A48-9723-584FADCB2FE3Q88688550-FD2A5881-9D54-400A-A699-182CA87ACE7CQ89032137-A3661D47-66FD-46B7-90E5-794E1E23EB1A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Darrell J Yamashiro
@ast
Darrell J Yamashiro
@en
Darrell J Yamashiro
@es
Darrell J Yamashiro
@nl
Darrell J Yamashiro
@sl
type
label
Darrell J Yamashiro
@ast
Darrell J Yamashiro
@en
Darrell J Yamashiro
@es
Darrell J Yamashiro
@nl
Darrell J Yamashiro
@sl
prefLabel
Darrell J Yamashiro
@ast
Darrell J Yamashiro
@en
Darrell J Yamashiro
@es
Darrell J Yamashiro
@nl
Darrell J Yamashiro
@sl
P106
P31
P496
0000-0002-1250-0235